Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Trabeculectomy with mitomycin C in glaucoma associated with uveitis.

Katia Novak-Laus1, Zdravko Mandić, Renata Iveković

  • 1University Department of Ophthalmology, Clinical Hospital, Systers of Mercy, Zagreb, Croatia.

Collegium Antropologicum
|October 1, 2005
PubMed
Summary

Mitomycin C (MMC) may improve short-term success for uveitic glaucoma patients undergoing trabeculectomy. This surgery helps lower intraocular pressure (IOP) but carries risks of complications and inflammation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A multiphase national study on patient glaucoma care priorities from the perspectives of patients and clinicians in Croatia.

European journal of ophthalmology·2026
Same author

Can Insulin Drops Accelerate Corneal Healing After Corneal Cross-Linking? A Preliminary Case Series.

Medicina (Kaunas, Lithuania)·2025
Same author

DIFFERENCES BETWEEN AQUEOUS HUMOR AND SERUM CONCENTRATIONS OF BDNF AND PPARG GENETIC VARIANTS IN GLAUCOMA PATIENTS.

Acta clinica Croatica·2025
Same author

THYROID-ASSOCIATED OPHTHALMOPATHY IN A HYPOTHYROID PATIENT.

Acta clinica Croatica·2025
Same author

SUPERFICIAL VESSEL DENSITY, RETINAL NERVE FIBER LAYER THICKNESS, AND VISUAL FIELD LOSS IN PRIMARY OPEN-ANGLE AND PSEUDOEXFOLIATIVE GLAUCOMA.

Acta clinica Croatica·2025
Same author

Competency-based European training requirements for the specialty of ophthalmology. Recommendations from the UEMS section of ophthalmology and the European Board of Ophthalmology.

Acta ophthalmologica·2025

Area of Science:

  • Ophthalmology
  • Glaucoma Research
  • Surgical Innovation

Background:

  • Uveitic glaucoma presents unique challenges for surgical management.
  • Patients with uveitic glaucoma face high risks of trabeculectomy failure due to age, inflammation, and complications.

Purpose of the Study:

  • To evaluate the efficacy of intraoperative mitomycin C (MMC) in enhancing trabeculectomy success rates.
  • To analyze intraocular pressure (IOP) control and complication rates after MMC-augmented trabeculectomy in uveitic glaucoma patients.

Main Methods:

  • Retrospective evaluation of 22 trabeculectomies in 22 patients with uveitic glaucoma.
  • Analysis of intraoperative mitomycin C (MMC) application's effect on success rates, IOP, and complications.
  • Mean follow-up of 10.6 months.

Related Experiment Videos

Main Results:

  • 68.2% of patients achieved target IOP (<21mmHg) without medication.
  • Statistically significant reduction in IOP observed postoperatively (p < 0.001).
  • Early and late complications included choroidal detachment, shallow anterior chamber, hyphema, macular edema, cataract, and elevated IOP.

Conclusions:

  • Intraoperative mitomycin C (MMC) application appears beneficial for short-term trabeculectomy success in uveitic glaucoma.
  • Further research is needed to confirm long-term efficacy and manage associated complications.